Caribou BiosciencesCRBU
那斯達克 · USD
1.57
+0.03
(+1.62%)
盤中 09/02 12:55 (UTC+8)
09/02 12:55 (UTC+8)
Caribou BiosciencesCRBU
1.57
+0.03
(+1.62%)
財務數據
損益表
- 0.02
- 0.03
- 0.02
- 0.02
- 0.02
- 0.03
- 0.02
- 0.04
- 0.02
- 0.01
- -31.73
- 42.61
- -41.57
- 2.62
- 13.29
- 13.34
- -17.59
- 79.30
- -39.18
- -37.46
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 1,499 | 2,397 | 3,941 | 2,198 | 2,667 | 2,353 | 2,077 | 2,024 | 3,464 | 2,429 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 1,499 | 2,397 | 3,941 | 2,198 | 2,667 | 2,353 | 2,077 | 2,024 | 3,464 | 2,429 |
營業費用 | 26,838 | 28,677 | 32,394 | 31,598 | 50,245 | - | - | - | - | - |
研發費用 | 18,942 | 20,611 | 23,815 | 22,401 | 27,692 | 35,531 | 30,464 | 30,421 | 35,480 | 33,788 |
推銷及管理費用 | 7,896 | 8,066 | 8,579 | 9,197 | 10,403 | 9,735 | 10,488 | 9,841 | 11,485 | 14,643 |
非經常性項目費用 | - | - | - | - | 12,150 | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -25,339 | -26,280 | -28,453 | -29,400 | -47,578 | -42,913 | -38,875 | -38,238 | -43,501 | -46,002 |
其他收入及費用 | 1,057 | 1,195 | 1,415 | 1,852 | -6,520 | 2,922 | 3,376 | 3,554 | 5,804 | 4,768 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -24,282 | -25,085 | -27,038 | -27,548 | -54,098 | -39,991 | -35,499 | -34,684 | -37,697 | -41,234 |
所得稅 | - | - | -550 | - | - | - | -9 | - | - | - |
稅後純益 | -24,282 | -25,085 | -26,488 | -27,548 | -54,098 | -39,991 | -35,490 | -34,684 | -37,697 | -41,234 |
基本每股稅後盈餘(元) | -0.24 | -0.26 | -0.28 | -0.30 | -0.58 | -0.43 | -0.39 | -0.38 | -0.42 | -0.46 |
稀釋每股稅後盈餘(元) | -0.24 | -0.26 | -0.28 | -0.30 | -0.58 | -0.43 | -0.39 | -0.38 | -0.42 | -0.46 |
基本平均股數(千股) | 100985.00 | 95861.00 | 94536.00 | 93293.00 | 93028.00 | 92679.00 | 91161.00 | 90455.00 | 90340.00 | 89302.00 |
稀釋平均股數(千股) | 100985.00 | 95861.00 | 94536.00 | 93293.00 | 93028.00 | 92679.00 | 91161.00 | 90455.00 | 90340.00 | 89302.00 |
還原基本每股稅後盈餘(元) | -0.24 | -0.26 | -0.28 | -0.30 | -0.58 | -0.43 | -0.39 | -0.38 | -0.42 | -0.46 |
還原稀釋每股稅後盈餘(元) | -0.24 | -0.26 | -0.28 | -0.30 | -0.58 | -0.43 | -0.39 | -0.38 | -0.42 | -0.46 |
還原基本平均股數(千股) | 100,985 | 95,861 | 94,536 | 93,293 | 93,028 | 92,679 | 91,161 | 90,455 | 90,340 | 89,302 |
還原稀釋平均股數(千股) | 100,985 | 95,861 | 94,536 | 93,293 | 93,028 | 92,679 | 91,161 | 90,455 | 90,340 | 89,302 |
EBITDA(千元) | -23,701 | -24,705 | -26,516 | -27,152 | -53,224 | -39,278 | -35,333 | -34,730 | -37,787 | -42,063 |